Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Emma M. Tillman, Cameron McKinzie, Dave Young, Charissa Kam |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
by: Charissa W. Kam, et al.
Published: (2024)
by: Charissa W. Kam, et al.
Published: (2024)
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025)
by: Cindy L. Williams, et al.
Published: (2025)
Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
by: Cameron J. McKinzie, et al.
Published: (2024)
by: Cameron J. McKinzie, et al.
Published: (2024)
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor
by: Richard De Vuyst, et al.
Published: (2024)
by: Richard De Vuyst, et al.
Published: (2024)
Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis
by: Rebecca S. Pettit, et al.
Published: (2024)
by: Rebecca S. Pettit, et al.
Published: (2024)
Roadmap to Global Cystic Fibrosis Care
by: Samya Z. Nasr, et al.
Published: (2025)
by: Samya Z. Nasr, et al.
Published: (2025)
E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
by: Maryam Sahibqran, et al.
Published: (2024)
by: Maryam Sahibqran, et al.
Published: (2024)
Implementation of Cystic Fibrosis Responsibility, Independence, Self‐Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial
by: Merve Selcuk Balcı, et al.
Published: (2025)
by: Merve Selcuk Balcı, et al.
Published: (2025)
Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
by: Brittany A. Wright, et al.
Published: (2025)
by: Brittany A. Wright, et al.
Published: (2025)
Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and Inequality
by: Marco Zampoli, et al.
Published: (2025)
by: Marco Zampoli, et al.
Published: (2025)
Acceptability of Telehealth Post‐Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis
by: Jaclyn Davis, et al.
Published: (2025)
by: Jaclyn Davis, et al.
Published: (2025)
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
by: Tyler Shugg, et al.
Published: (2025)
by: Tyler Shugg, et al.
Published: (2025)
Stakeholder Priorities for Cystic Fibrosis Mental Health Research: A Community and Provider Survey
by: Anna M. Georgiopoulos, et al.
Published: (2026)
by: Anna M. Georgiopoulos, et al.
Published: (2026)
Cystic Fibrosis Year in Review 2024
by: Adrienne P. Savant
Published: (2025)
by: Adrienne P. Savant
Published: (2025)
Pathophysiology of Cystic Fibrosis Liver Disease
by: Vania L. Kasper, et al.
Published: (2024)
by: Vania L. Kasper, et al.
Published: (2024)
Transforming Care in Cystic Fibrosis: The Long‐Term Impact of Quality Improvement Projects on Clinical Outcomes
by: S. Karabulut, et al.
Published: (2026)
by: S. Karabulut, et al.
Published: (2026)
Co‐Design of a Novel Telehealth Exercise Model of Care for Adults With Cystic Fibrosis
by: Megan Poulsen, et al.
Published: (2026)
by: Megan Poulsen, et al.
Published: (2026)
Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use
by: Khizra Farhan Ahmad, et al.
Published: (2026)
by: Khizra Farhan Ahmad, et al.
Published: (2026)
Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
by: Rebecca Gallardo, et al.
Published: (2026)
by: Rebecca Gallardo, et al.
Published: (2026)
Expanding Cystic Fibrosis Registries to the Rest of the World
by: Lutz Naehrlich
Published: (2026)
by: Lutz Naehrlich
Published: (2026)
Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor‐Tezacaftor‐Ivacaftor Therapy
by: Kimberly Pasley, et al.
Published: (2024)
by: Kimberly Pasley, et al.
Published: (2024)
Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
by: Suzanne Kroes, et al.
Published: (2026)
by: Suzanne Kroes, et al.
Published: (2026)
Disparities in Access to Cystic Fibrosis Therapy Across Countries
by: Bulent Karadag
Published: (2026)
by: Bulent Karadag
Published: (2026)
“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)
Body Image Perceptions and Elexacaftor/Tezacaftor/Ivacaftor (ETI) Use in Adolescents and Young Adults Living With Cystic Fibrosis
by: Emma R. Lyons, et al.
Published: (2025)
by: Emma R. Lyons, et al.
Published: (2025)
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
by: Leslie Huang, et al.
Published: (2025)
by: Leslie Huang, et al.
Published: (2025)
Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
by: Laurie P. Murray, et al.
Published: (2025)
by: Laurie P. Murray, et al.
Published: (2025)
Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
by: Chelsea Flora, et al.
Published: (2026)
by: Chelsea Flora, et al.
Published: (2026)
The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
by: Rebecca J. Vitale, et al.
Published: (2026)
by: Rebecca J. Vitale, et al.
Published: (2026)
Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
by: Sean Coyne, et al.
Published: (2024)
by: Sean Coyne, et al.
Published: (2024)
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
by: Gabriela R. Oates, et al.
Published: (2025)
by: Gabriela R. Oates, et al.
Published: (2025)
Exploring Bone Health in Cystic Fibrosis: A Study From a Lung Transplantation Center and Strategy for Clinical Care
by: Gökçen Kartal Öztürk, et al.
Published: (2025)
by: Gökçen Kartal Öztürk, et al.
Published: (2025)
Domain‐Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis
by: Jeremy P. Tervo, et al.
Published: (2025)
by: Jeremy P. Tervo, et al.
Published: (2025)
Pica‐Induced Airway Obstruction in Paediatric Cystic Fibrosis: An Unexpected Culprit
by: Anna Šmejkalová, et al.
Published: (2025)
by: Anna Šmejkalová, et al.
Published: (2025)
A Dose of Hope: Successful Tobramycin Desensitization in Pediatric Cystic Fibrosis
by: Isabel G. Wedig, et al.
Published: (2025)
by: Isabel G. Wedig, et al.
Published: (2025)
Knowledge, Attitudes, and Behaviors of Cystic Fibrosis Patients on Reproductive Health in Turkiye
by: Hande Yuce Ozdemir, et al.
Published: (2025)
by: Hande Yuce Ozdemir, et al.
Published: (2025)
Infant Lung Function in Cystic Fibrosis: A Real‐World Study
by: Michele Arigliani, et al.
Published: (2025)
by: Michele Arigliani, et al.
Published: (2025)
Anxiety in the Pediatric Cystic Fibrosis Population: Evaluation of a Younger Cohort
by: Jemilla Strode Smith, et al.
Published: (2025)
by: Jemilla Strode Smith, et al.
Published: (2025)
Objectively Monitored Sleep in School‐Age Children With Cystic Fibrosis and Their Parents
by: Andrea L. Fidler, et al.
Published: (2025)
by: Andrea L. Fidler, et al.
Published: (2025)
Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
by: Elizabeth Clarke, et al.
Published: (2024)
by: Elizabeth Clarke, et al.
Published: (2024)
Similar Items
-
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
by: Charissa W. Kam, et al.
Published: (2024) -
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025) -
Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
by: Cameron J. McKinzie, et al.
Published: (2024) -
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor
by: Richard De Vuyst, et al.
Published: (2024) -
Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis
by: Rebecca S. Pettit, et al.
Published: (2024)